Lung Cancer

Top Story

Karmanos Cancer Institute president elected to Association of American Cancer Institutes board

Karmanos Cancer Institute president elected to Association of American Cancer Institutes board
October 20, 2017

Gerold Bepler, MD, PhD, has been elected to the Association of American Cancer Institutes’ board of directors.

Bepler, president and CEO of Barbara Ann Karmanos Cancer Institute, will serve a 3-year term.

In the Journals Plus

Fewer newly diagnosed patients with cancer lack insurance after ACA

October 19, 2017
Uninsurance rates among patients newly diagnosed with cancer dropped one-third during the Affordable Care Act’s first year of implementation, according to study…
Meeting News

PIK3CA mutation linked to brain metastases in large cell neuroendocrine carcinoma

October 19, 2017
PIK3CA mutation defined a distinct phenotype of large cell neuroendocrine carcinoma of the lung characterized by brain metastases, according to study results presented…
Meeting News

Ipilimumab, nivolumab shows promising control of mesothelioma

October 18, 2017
The combination of nivolumab and ipilimumab showed a promising rate of 12-week disease control among patients with recurrent malignant pleural mesothelioma, according to…
More Headlines »
CME

Combination Strategies in Melanoma Management: What’s New and What’s Next

This activity is supported by an educational grant from Genentech, Inc.

Melanoma is the sixth most common cancer in the United States and the deadliest form of skin cancer. Although it is…
More »
Video
Meeting News

VIDEO: Gefitinib may ‘change the paradigm’ to treat lung cancer

August 10, 2017
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress

CME

Multiple Myeloma Patient Management: Embracing New Advancements, Overcoming New Challenges

Support for this activity has been provided through educational grants from Amgen; Celgene Corporation; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Oncology.

The multiple myeloma clinical landscape has evolved significantly, with not only 10 new drugs but also new staging…
More »
Advertisement
Advertisement